PAB10052
antibody from Abnova Corporation
Targeting: GLI3
ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PAB10052 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#PAB10052, RRID:AB_1674721
- Product name
- GLI3 polyclonal antibody
- Antibody type
- Polyclonal
- Description
- Rabbit polyclonal antibody raised against synthetic peptide of GLI3.
- Storage
- Store at 4°C. For long term storage store at -20°C.Aliquot to avoid repeated freezing and thawing.
Submitted references Hedgehog related protein expression in breast cancer: gli-2 is associated with poor overall survival.
Acute lymphoblastic leukemia in a patient with Greig cephalopolysyndactyly and interstitial deletion of chromosome 7 del(7)(p11.2 p14) involving the GLI3 and ZNFN1A1 genes.
Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations.
Clinical and molecular delineation of the Greig cephalopolysyndactyly contiguous gene deletion syndrome and its distinction from acrocallosal syndrome.
Im S, Choi HJ, Yoo C, Jung JH, Jeon YW, Suh YJ, Kang CS
Korean journal of pathology 2013 Apr;47(2):116-23
Korean journal of pathology 2013 Apr;47(2):116-23
Acute lymphoblastic leukemia in a patient with Greig cephalopolysyndactyly and interstitial deletion of chromosome 7 del(7)(p11.2 p14) involving the GLI3 and ZNFN1A1 genes.
Mendoza-Londono R, Kashork CD, Shaffer LG, Krance R, Plon SE
Genes, chromosomes & cancer 2005 Jan;42(1):82-6
Genes, chromosomes & cancer 2005 Jan;42(1):82-6
Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations.
Johnston JJ, Olivos-Glander I, Killoran C, Elson E, Turner JT, Peters KF, Abbott MH, Aughton DJ, Aylsworth AS, Bamshad MJ, Booth C, Curry CJ, David A, Dinulos MB, Flannery DB, Fox MA, Graham JM, Grange DK, Guttmacher AE, Hannibal MC, Henn W, Hennekam RC, Holmes LB, Hoyme HE, Leppig KA, Lin AE, Macleod P, Manchester DK, Marcelis C, Mazzanti L, McCann E, McDonald MT, Mendelsohn NJ, Moeschler JB, Moghaddam B, Neri G, Newbury-Ecob R, Pagon RA, Phillips JA, Sadler LS, Stoler JM, Tilstra D, Walsh Vockley CM, Zackai EH, Zadeh TM, Brueton L, Black GC, Biesecker LG
American journal of human genetics 2005 Apr;76(4):609-22
American journal of human genetics 2005 Apr;76(4):609-22
Clinical and molecular delineation of the Greig cephalopolysyndactyly contiguous gene deletion syndrome and its distinction from acrocallosal syndrome.
Johnston JJ, Olivos-Glander I, Turner J, Aleck K, Bird LM, Mehta L, Schimke RN, Heilstedt H, Spence JE, Blancato J, Biesecker LG
American journal of medical genetics. Part A 2003 Dec 15;123A(3):236-42
American journal of medical genetics. Part A 2003 Dec 15;123A(3):236-42
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Western blot using GLI3 polyclonal antibody (Cat # PAB10052) shows detection of multiple bands in human lung lysate believed to be GLI3.Lanes contain 20 ug of whole cell lysates from 1 - human brain, 2 - human lung, 3 - human spleen, 4 - mouse brain and 5 - mouse lung.While no recognizable staining can be seen on mouse tissue, human lung shows what may be truncated GLI3 (~80 KDa).This identity of the strong band at ~50 KDa is unknown.After blocking, the membrane was probed with the primary antibody diluted to 1:500.For detection use HRP Gt-a-Rabbit IgG.Detection of GLI3 by western blot may be enhanced if nuclear extracts are used instead of whole cell lysates as the expression/abundance of GLI3 is likely to be low.Furthermore, GLI3 expression is likely to be developmentally regulated and induced, making it difficult to detect in whole tissue homogenates.
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Immunohistochemistry of GLI3 polyclonal antibody (Cat # PAB10052) was used at a 0.625 ug/mL to detect GLI3 in a variety of tissues.Strong nuclear and smooth muscle staining was noted to be consistent with previously published reports.Specific staining was noted in tissue from adrenal, brain, glioblastoma, colon, heart, kidney, lung, liver, skeletal muscle, ovary, pancreas, placenta, skin, spleen, stomach, testes, thymus, thyroid, tonsil and uterus.This image shows GLI3 staining of human glioblastoma.Tissue was formalin-fixed and paraffin embedded.Personal Communication, Tina Roush, Life Span Biosciences, Seattle, WA.
- Validation comment
- Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)